Clinical Trial Update: Observational Post-authorization Studies Carboplatin, Paclitaxel and Bevacizumab

View source ↗

Summary

This clinical trial update describes the completion of an observational post-authorization study evaluating the combination of carboplatin, paclitaxel, and beva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Spanish Lung Cancer Group | Conditions: Nonsquamous Nonsmall Cell Neoplasm of Lung | Status: COMPLETED